Monogram Orthopaedics (NASDAQ:MGRM) Given New $5.40 Price Target at Roth Mkm

Monogram Orthopaedics (NASDAQ:MGRM) had its price target raised by analysts at Roth Mkm from $4.00 to $5.40 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s target price suggests a potential upside of 49.29% from the company’s previous close.

Separately, Roth Capital upgraded shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

Monogram Orthopaedics Trading Down 1.4 %

Shares of MGRM traded down $0.05 during mid-day trading on Tuesday, reaching $3.62. The company had a trading volume of 1,107,081 shares, compared to its average volume of 729,697. The stock has a market cap of $127.64 million, a price-to-earnings ratio of -7.70 and a beta of 1.66. The firm has a fifty day simple moving average of $2.56 and a 200-day simple moving average of $2.49. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90.

Monogram Orthopaedics (NASDAQ:MGRM) last announced its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03. As a group, equities analysts predict that Monogram Orthopaedics will post -0.49 EPS for the current fiscal year.

Hedge Funds Weigh In On Monogram Orthopaedics

Several hedge funds and other institutional investors have recently made changes to their positions in MGRM. Jane Street Group LLC acquired a new position in shares of Monogram Orthopaedics during the 4th quarter valued at $25,000. Wells Fargo & Company MN lifted its holdings in shares of Monogram Orthopaedics by 286.6% during the 4th quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock valued at $27,000 after acquiring an additional 8,597 shares in the last quarter. Barclays PLC acquired a new position in shares of Monogram Orthopaedics during the 3rd quarter valued at $29,000. Orion Portfolio Solutions LLC acquired a new position in shares of Monogram Orthopaedics during the 4th quarter valued at $31,000. Finally, State Street Corp acquired a new position in shares of Monogram Orthopaedics during the 3rd quarter valued at $62,000. Institutional investors and hedge funds own 0.45% of the company’s stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.